Roland Bassett
Overview
Explore the profile of Roland Bassett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
2931
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nieto Y, Ramdial J, Valdez B, Thall P, Bassett R, Barnett M, et al.
Clin Cancer Res
. 2025 Jan;
PMID: 39804167
Purpose: More active high-dose chemotherapy (HDC) regimens are needed for autologous stem-cell transplantation (ASCT) for refractory lymphomas. Seeking HDC enhancement with a poly(ADP-ribose) polymerase (PARP) inhibitor, we observed marked synergy...
2.
Jensen C, Wong V, Likhari G, Daoud T, Ahmad M, Bassett R, et al.
Eur Radiol
. 2024 Dec;
PMID: 39699673
Objective: To assess the accuracy of CT spectral HU curve assessment of hypodense liver lesions. Methods: In this retrospective HIPAA-compliant study (January 2016 through May 2023), patients with biopsy-proven pancreatic...
3.
Chen J, Addanki S, Roy D, Bassett R, Kalashnikova E, Spickard E, et al.
BMC Cancer
. 2024 Aug;
24(1):1016.
PMID: 39148033
Background: Triple negative breast cancer (TNBC) is an aggressive subtype with poor prognosis. We aimed to determine whether circulating tumor DNA (ctDNA) and circulating tumor cell (CTC) could predict response...
4.
Lim B, Seth S, Yam C, Huo L, Fujii T, Lee J, et al.
Cell Rep Med
. 2024 Jun;
5(6):101595.
PMID: 38838676
Luminal androgen receptor (LAR)-enriched triple-negative breast cancer (TNBC) is a distinct subtype. The efficacy of AR inhibitors and the relevant biomarkers in neoadjuvant therapy (NAT) are yet to be determined....
5.
Jimenez C, Habra M, Campbell M, Tamsen G, Cruz-Goldberg D, Long J, et al.
Lancet Oncol
. 2024 Apr;
25(5):658-667.
PMID: 38608693
Background: Metastatic phaeochromocytomas and paragangliomas (MPPGs) are orphan diseases. Up to 50% of MPPGs are associated with germline pathogenic variants of the SDHB gene. These tumours and many non-familial MPPGs...
6.
Koutroumpakis E, Mohamed A, Chaftari P, Rosenthal D, Gujral D, Nutting C, et al.
Radiother Oncol
. 2024 Mar;
195:110220.
PMID: 38467343
Introduction: We prospectively evaluated morphologic and functional changes in the carotid arteries of patients treated with unilateral neck radiation therapy (RT) for head and neck cancer. Methods: Bilateral carotid artery...
7.
Marin D, Li Y, Basar R, Rafei H, Daher M, Dou J, et al.
Nat Med
. 2024 Jan;
30(3):772-784.
PMID: 38238616
There is a pressing need for allogeneic chimeric antigen receptor (CAR)-immune cell therapies that are safe, effective and affordable. We conducted a phase 1/2 trial of cord blood-derived natural killer...
8.
Harrison R, Tang M, Shih K, Khan M, Pham L, De Moraes A, et al.
BMC Palliat Care
. 2024 Jan;
23(1):13.
PMID: 38212765
Purpose: In this study, we aimed to assess the clinical characteristics, reasons for referral, and outcomes of patients with brain metastases (BM) referred to the supportive care center. Methods: Equal...
9.
Omofoye T, Vlahos I, Marom E, Bassett R, Blasinska K, Ye X, et al.
Clin Imaging
. 2023 Dec;
106:110049.
PMID: 38070475
Objective: Anecdotal reports from imaging facilities globally suggest growing radiology interpretation reporting delays. This pilot study's primary aim was to estimate the backlog of formal interpretation of imaging examinations. Methods:...
10.
Davaro E, Tinnirello A, Bevers T, Milbourne A, Bassett R, Stewart J, et al.
Cancer Cytopathol
. 2023 Dec;
132(3):152-160.
PMID: 38054363
Background: To evaluate the efficacy of Cobas human papillomavirus (HPV) testing to predict cervical intraepithelial neoplasia of grade 2 or higher (CIN2+), Cobas HPV testing results were correlated with follow-up...